Search

Home
Search

Prof. Dr. İbrahim Suat Öktem

View Details

EDUCATION

Specialization: Erciyes University Faculty of Medicine, Department of Neurosurgery
Medical Education: Atatürk University Faculty of Medicine

WORK EXPERIENCE

2025 – Present: Private Hüma Hospital
2009 – Present: Professor – Erciyes University Faculty of Medicine, Department of Neurosurgery
2001-2009: Associate Professor – Erciyes University Faculty of Medicine, Department of Neurosurgery
1991-2001: Assistant Professor – Erciyes University Faculty of Medicine, Department of Neurosurgery
1985-1991: Erciyes University Faculty of Medicine, Department of Neurosurgery
1983-1985: Anamur SSK Health Station

AREAS OF INTEREST

Congenital brain and spinal anomalies
Hydrocephalus (fluid accumulation in the brain)
Lumbar and cervical hernia surgeries
Spinal canal stenosis surgery
Brain, spinal cord, and cyst tumor surgeries
Brain trauma and hemorrhages

SCIENTIFIC PUBLICATION BOARD MEMBERSHIPS

Turkey Clinics Journal of Medical Sciences
Fırat Medical Journal

He has a total of 76 scientific publications (50 international, 26 national) and 131 congress presentations (6 international, 125 national). Additionally, he has authored 11 review articles and contributed 11 chapters in 6 books.

He has been an invited speaker 78 times at national scientific congresses, conferences, symposiums, and courses. In 2005, he organized one scientific meeting and served on the organizing committee of 7 congresses and scientific meetings.

Furthermore, he served as the Congress Secretary of the Turkish Neurosurgery Association Scientific Congress in 2021. He has worked as a special issue editor for a neurosurgery journal and as an editor for the pediatric section of a neurosurgery book.

He has supervised 6 doctoral theses, and his scientific studies have received citations.

SCIENTIFIC PUBLICATIONS

I- Articles

A- Published in Journals Indexed in SSCI, AHCI, or SCI

Koç RK, Akdemir H, Kandemir O, Paşaoğlu H, Öktem İS, Paşaoğlu A: The therapeutic value of naloxone and mannitol in experimental focal cerebral ischemia. Res Exp Med 194:277-285, 1994
Akdemir H, Selçuklu A, Paşaoğlu A, Öktem İS, Kavuncu İA: Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev 18:95-100, 1995
Paşaoğlu A, Kurtsoy A, Koç RK, Kontaş O, Akdemir H, Öktem İS, Selçuklu A, Kavuncu A: Cranioplasty with bone flaps preserved under the scalp. Neurosurg Rev 19:153-156, 1996
Koç RK, Akdemir H, Öktem İS, Meral M, Menkü A: Acute subdural hematoma; outcome and outcome prediction. Neurosurg Rev 20:239-244, 1997
Karaküçük Eİ, Paşaoğlu H, Paşaoğlu A, Öktem S: Endogenous neuropeptides in patients with acute traumatic head injury II. Neuropeptides 31:259-263, 1997
Öktem İS, Akdemir H, Koç K, Menkü A, Tucer B, Selçuklu A, Turan C: Migration of abdominal catheter of ventriculoperitoneal shunt into the scrotum. Acta Neurochir 140:167-170, 1998
Koç RK, Paşaoğlu A, Menkü A, Öktem İS, Meral M: Extradural hematoma of the posterior cranial fossa. Neurosurg Rev 21:52-57, 1998
Koç RK, Akdemir H, Karaküçük EI, Öktem İS, Menkü A: Effect of methylprednisolone, tirilazad mesylate, and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 37:29-32, 1999
Koç RK, Kurtsoy A, Paşaoğlu H, Karaküçük EI, Öktem İS, Meral M: Lipid peroxidation and edema in experimental brain injury: Comparison of treatment with methylprednisolone, tirilazad mesylate, and vitamin E. Res Exp Med 199:21-28, 1999
Akdemir H, Kontaş O, Öktem İS, Tucer B, Kafadar H, Paşaoğlu A: A new subtype of meningioma. Neurosurg Rev 22:50-53, 1999
Akdemir H, Kurtsoy A, Öktem İS, Menkü A, Koç RK, Tucer B: Failure of open third ventriculostomy for shunt infections in infants. Pediatr Neurosurg 30:305-309, 1999
Öktem İS, Menkü A, Akdemir H, Kontaş O, Kurtsoy A, Koç RK: Therapeutic effect of tirilazad mesylate (U-74006F), mannitol, and their combination on experimental ischemia. Res Exp Med 199:231-242, 2000
Öktem İS, Akdemir H, Kurtsoy A, Koç RK, Menkü A: Hemilaminectomy for the removal of spinal lesions. Spinal Cord 38:92-96, 2000
Kurtsoy A, Canbay S, Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Effect of EGb-761 on vasospasm in experimental subarachnoid hemorrhage. Res Exp Med 199:207-215, 2000
Kurtsoy A, Öktem İS, Koç RK, Menkü A, Akdemir H, Tucer B: Surgical treatment of thalamic hematomas via the contralateral transcallosal approach. Neurosurg Rev 24:108-113, 2001
Akdemir H, Aşık Z, Paşaoğlu H, Karaküçük İ, Öktem İS, Koç RK: The effect of allopurinol on focal cerebral ischemia: an experimental study in rabbits. Neurosurg Rev 24:131-135, 2001
Koç RK, Menkü A, Akdemir H, Tucer B, Kurtsoy A, Öktem İS: Cervical spondylotic myelopathy and radiculopathy treated by oblique corpectomies without fusion. Neurosurg Rev 27:252-258, 2004
Kurtsoy A, Menkü A, Tucer B, Öktem İS, Akdemir H, Koç RK: Transbasal approaches: surgical details, pitfalls, and avoidances. Neurosurg Rev 27:267-273, 2004
Kurtsoy A, Menkü A, Tucer B, Öktem İS, Akdemir H: Neuronavigation in skull base tumors. Minim Invas Neurosurg 48:7-12, 2005
Menkü A, Akdemir H, Durak AC, Öktem İS: Successful surgical excision of juvenile-type spinal arteriovenous malformation in two stages following partial embolization. Minim Invas Neurosurg 48:57-62, 2005
Akdemir H, Öktem S, Menkü A, Tucer B, Tuğcu B, Günaldı Ö: Image-Guided Microsurgical Management of Small Arteriovenous Malformations: Role of Neuronavigation and Intraoperative Doppler Sonography. Minim Invas Neurosurg 50:163-169, 2007
Öktem İS, Menkü A, Özdemir A: When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus? Turkish Neurosurg 18:387-91, 2008
Menkü A, Koç R.K, Öktem IS, Tucer B, Kurtsoy A: Laminoplasty with Miniplates for Posterior Approach in Thoracic and Lumbar Intraspinal Surgery. Turkish Neurosurg 20:27-32, 2010
Köksal V, Öktem İS: Ventriculosubgaleal shunt procedure and its long-term outcomes in premature infants with post-hemorrhagic hydrocephalus. Childs Nerv Syst 26:1505-1515, 2010
Küçük A, Tümtürk A, Gergin İŞ, Oral Ş, Görkem SB, Kurtsoy A, Madenoğlu H, Öktem İS: The Management of Blood Loss in Non-Syndromic Craniosynostosis Patients Undergoing Barrel Stave Osteotomy. Turkish Neurosurg 27:138-141, 2017
Yay A, Goktepe Ö, Bahadir A, Özdamar S, Öktem IS, Çoruh A, Baran M: Assessment of markers expressed in human hair follicles according to different skin regions. Adv Clin Exp Med 27:929–939, 2018
Köksal V, Mercantepe T, Tümkaya M, Oktem IS: Less use of bipolar cautery can prevent post-laminectomy epidural fibrosis. Turkish Neurosurg 30:217-224, 2020
Kamaşak B, Ulcay T, Küçük A, Karaman F, İpekten F, Öktem İS, Aycan K: A new supportive approach in the diagnosis of Chiari malformation type 1 in pediatric patients. Childs Nerv Syst 39:1581-1587, 2023

B- Published in Peer-Reviewed National and International Journals

[List continues with national and international peer-reviewed journals...]

II- Other Studies (Technical Notes, Comments, Case Reports, Letters to the Editor, etc.)

Here is the translated version of your text:

A- Articles Published in Journals Indexed in SSCI, AHCI, or SCI

Paşaoğlu A, Orhon C, Akdemir H, Uzunoğlu H, Öktem S, Yardım Ş: Subperiosteal intraorbital hematoma following minor head trauma. A case report. Acta Neurochir 97:83-85, 1989
Akdemir H, Paşaoğlu A, Ekinciler ÖF, Selçuklu A, Karaküçük S, Öktem İS: Unilateral naso-orbital meningocele and bilateral congenital fistulae of the lacrimal passages. Acta Ophtal 69:680-683, 1991
Öktem İS, Selçuklu A, Kurtsoy A, Kavuncu İA, Paşaoğlu A: Migration of a bullet in the spinal canal. A case report. Surg Neurol 44:548-550, 1995
Kurtsoy A, Paşaoğlu A, Koç RK, Öktem İS, Kontaş O: Cerebellopontine angle germinoma. A case report. Neurosurg Rev 19:127-130, 1996
Kurtsoy A, Koç RK, Öktem İS, Kontaş O, Selçuklu A, Paşaoğlu A: Ganglioglioma of conus medullaris. A case report. Neurosurg Rev 20:55-58, 1997
Akdemir H, Öktem İS, Koç RK, Kavuncu İ: Postoperative intraradicular lumbar disc herniation. A case report. Neurosurg Rev 20:71-74, 1997
Selçuklu A, Kurtsoy A, Öktem İS, Koç RK, Kavuncu İA: Postoperative mutism after the clipping of a distal anterior cerebral artery aneurysm. A case report. Neurosurg Rev 20:214-216, 1997
Koç RK, Paşaoğlu A, Kurtsoy A, Öktem İS, Kavuncu İA: Acute spontaneous subdural hematoma of arterial origin. A report of five cases. Surg Neurol 47:9-11, 1997
Öktem İS, Akdemir H, Sümerkan B, Koç RK, Menkü A, Tümtürk F: Cerebellar abscess due to Nocardia asteroides. Acta Neurochir 141:217-218, 1999
Kurtsoy A, Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Successful surgical treatment of a thalamic hydatid cyst with a contralateral transcallosal approach. Pediatr Neurosurg 31:96-99, 1999
Koç RK, Kurtsoy A, Öktem İS, Akdemir H: Growing skull fracture of the orbital roof. Pediatr Neurosurg 30:35-38, 1999
Koç RK, Akdemir H, Öktem İS, Menkü A: Intradural lumbar disc herniation: Report of two cases. Neurosurg Rev 24:44-47, 2001
Koç RK, Akdemir H, Öktem İS, Kurtsoy A, Menkü A: Posterolaterally displaced type IIA odontoid fractures. Neurosurg Rev 24:143-146, 2001
Menkü A, Kurtsoy A, Tucer B, Öktem İS, Akdemir H: The surgical management of traumatic C6-C7 spondyloptosis in a patient without neurological deficits. A case report. Minim Invas Neurosurg 47:242-244, 2004
Akdemir H, Öktem İS, Tucer B, Menkü A, Başaslan K, Günaldı Ö: Intraoperative microvascular Doppler sonography in aneurysm surgery. Minim Invas Neurosurg 49:312-316, 2006
Baykan Z, Öktem İS, Çetinkaya F, Naçar M: Physician exposure to violence: A study performed in Turkey. Int J Occup Saf Ergon 21(3):291-297, 2015

B- Articles Published in Peer-Reviewed National and International Journals

Paşaoğlu A, Yardım Ş, Öktem İS, Selçuklu A, Akdemir H, Koç K: Acute spontaneous arterial subdural hematoma. A case report and review of the literature. Turkish Neurosurg 2:44-48, 1991
Kurtsoy A, Paşaoğlu A, Koç RK, Öktem İS, Kavuncu İA: Calvarial osteogenic sarcoma developing on Paget’s disease. Erciyes Med J 16:186-189, 1994
Öktem İS, Akdemir H, Paşaoğlu A, Kurtsoy A, Selçuklu A: Hydatid cyst of the posterior fossa. A case report. Erciyes Med J 16:303-306, 1994
Kurtsoy A, Paşaoğlu A, Koç RK, Öktem İS: Acute brain swelling during the evacuation of an intracerebral hematoma caused by primary progressive contralateral subdural hematoma: A case report. Erciyes Med J 17:77-80, 1995
Menkü A, Tucer B, Kurtsoy A, Öktem İS, Göçmez C, Akdemir H: Spontaneous cerebrospinal fluid rhinorrhea associated with temporal lobe meningoencephalocele in the lateral sphenoid sinus in an adult. Turkish Neurosurg 14:76-79, 2004

C- Articles Published in Non-Peer-Reviewed Journals (Faculty, Institute, Research Center Journals, and Encyclopedic Entries)

Durak AC, Özcan N, Kırnap M, Öktem İS: Brucella spondylodiscitis. Computed Tomography Bulletin 3:41-43, 1995
Madenoğlu H, Bilen A, Öktem İS, Akın A, Boyacı A: Anaesthetic management of vein of Galen aneurysms. A case report. Surgical Medicine Archives 4:193-195, 1997
Kurtsoy A, Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Akinetic mutism due to recurrent obstructive hydrocephalus. Surgical Medicine Archives 3:181-184, 1998

I- Review Articles

Öktem İS, Göçmez C: Spinal tumors in childhood. Turkiye Klinikleri J Pediatr Sci 3:80-85, 2007
Öktem İS, Göçmez C: Emergency neurosurgical approach in patients with mild and moderate head trauma. Turkiye Klinikleri J Surg Med Sci 3:27-31, 2007

III- Presented and Published Conference Papers

A- International Conferences

Ünal A, Öktem İS, Çetin M, Çelik F, Akdemir H: Activated Protein C Resistance with Deep Venous Thrombosis, Recurrent Pulmonary Embolism, and Cerebral Hemorrhage. A case report. XIV Meeting of the International Society of Haematology, 30 Aug-4 Sept 1997, Stockholm, Sweden (Poster)
Koç RK, Öktem İS, Kurtsoy A, Tucer B, Akdemir H: Adult diastematomyelia. 12th World Congress of Neurosurgical, 16-20 Sept 2001, Sydney, Australia (Poster)
Kurtsoy A, Akdemir H, Menkü A, Tucer B, Öktem İS, Koç RK: Neuronavigation in skull base tumors. 12th World Congress of Neurosurgical, 16-20 Sept 2001, Sydney, Australia (Poster)

B- National

Paşaoğlu A, Orhon C, Öktem İS, Uzunoğlu H, Akdemir H: Surgical Treatment in Pott's Abscesses. Turkish Neurosurgery Association Scientific Congress, May 1989, Antalya (Oral Presentation)

Paşaoğlu A, Orhon C, Öktem İS, Uzunoğlu H, Akdemir H: Surgical Approach in Thoracolumbar Trauma. Turkish Neurosurgery Association Scientific Congress, May 1989, Antalya (Oral Presentation)

Öktem İS, Paşaoğlu A, Patıroğlu TE, Selçuklu A, Akdemir H, Kılıç H: The Effect of Hyaluronidase in Experimental Brain Abscesses and Investigation of Its Mechanism. Turkish Neurosurgery Association Scientific Congress, May 21-26, 1991, Çeşme (Oral Presentation)

Bozkır MG, Aycan K, Öktem İS: Variations of the Circulus Arteriosus Cerebri. Anatomy Congress, June 27-30, 1991, Bursa (Oral Presentation)

Öktem İS, Paşaoğlu A, Akdemir H, Selçuklu A, Koç RK, Kurtsoy A: Prognosis of Minor Head Trauma. 10th Gevher Nesibe Medical Days, March 11-14, 1992, Kayseri (Oral Presentation)

Kök AH, Güraksın A, Öktem İS, Öztürk S: Retrospective Evaluation of Forensic Cases Related to Neurosurgery. 10th Gevher Nesibe Medical Days, March 11-14, 1992, Kayseri (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Meral M, Menkü A: Prognosis and Prognostic Factors in Acute Subdural Hematomas. Turkish Neurosurgery Association Scientific Congress, May 24-28, 1996, Çeşme (Oral Presentation)

Selçuklu A, Kavuncu İA, Koç RK, Alper M, Öktem İS, Menkü A: The Effect of Heparin on Capsule Formation in Experimental Brain Abscesses. Turkish Neurosurgery Association Scientific Congress, May 24-28, 1996, Çeşme (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Selçuklu A, Tucer B: Frequency of Transient Stenosis in Middle and Anterior Cerebral Arteries in Meningitis and Its Relationship with Clinical Findings. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A: Intradural Lumbar Disc Herniation; Presentation of Two Cases. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Poster Presentation)

Öktem İS, Akdemir H, Koç K, Menkü A, Tucer B, Selçuklu A: Migration of Ventriculoperitoneal Shunt into the Scrotum. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Oral Presentation)

Koç RK, Paşaoğlu A, Menkü A, Öktem İS, Meral M: Posterior Cranial Fossa Epidural Hematomas. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Oral Presentation)

Öktem İS, Selçuklu A, Koç K, Meral M, Menkü A, Akdemir H: Comparison of Aspiration + Drainage and Excision in the Treatment of Brain Abscesses. Turkish Neurosurgery Association Scientific Congress, May 16-20, 1997, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Diastematomyelia. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Poster Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B: Unilateral Hemilaminectomy in Spinal Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Poster Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Tethered Cord Syndrome. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Kontaş O, Tucer B, Menkü A, Tümtürk F: A New Subgroup of Meningiomas: Case Report. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Poster Presentation)

Koç RK, Akdemir H, Karaküçük Eİ, Öktem İS, Menkü A: The Effects of Methylprednisolone, Tirilazad Mesylate, and Vitamin E on Lipid Peroxidation in Experimental Spinal Cord Injury. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B: Syringomyelia. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B: Transcallosal Approach to Third Ventricular Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Selçuklu A: Outcome Analysis of Ventriculoperitoneal Shunt Infections. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Selçuklu A: Analysis of Posterior Cranial Fossa Epidural Hematomas. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Long-Term Follow-up of Patients with Chiari Malformation Type 1. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Effectiveness of Various Surgical Techniques in the Treatment of Spinal Cord Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Role of Stereotactic Biopsy in Brain Tumor Diagnosis. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Evaluation of Surgical Approaches in Aneurysm Cases. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Pediatric Neurosurgery Cases: A Retrospective Analysis. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Treatment and Follow-up of Hydrocephalus Patients. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Long-Term Results of Spinal Cord Decompression Surgeries. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Postoperative Outcomes of Brainstem Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Surgical Treatment of Cervical Spine Fractures. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Factors Affecting Survival in Glioblastoma Patients. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Analysis of Cranial Trauma Cases in a Neurosurgical Unit. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Clinical and Radiological Findings in Pituitary Adenomas. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: The Role of Endoscopic Surgery in Neurosurgery. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Surgical Approaches to Pineal Region Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Neurosurgical Interventions in Pediatric Epilepsy. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Evaluation of Postoperative Complications in Spinal Surgeries. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Koç RK, Akdemir H, Öktem İS, Menkü A, Tucer B, Kontaş O: Outcome of Patients with Cervical Spondylotic Myelopathy. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Öktem İS, Akdemir H, Koç RK, Menkü A, Tucer B, Kontaş O: Neurosurgical Management of Intramedullary Spinal Cord Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

Akdemir H, Öktem İS, Koç RK, Menkü A, Tucer B, Kontaş O: Surgical Strategies in Complex Cranial Base Tumors. Turkish Neurosurgery Association Scientific Congress, May 15-19, 1998, Antalya (Oral Presentation)

VI- Book

A- Contribution at the Chapter Level (National)

Öktem İS: Head Trauma. Sözüer E (ed), Emergency Aid and Trauma Handbook.
Feryal Printing, Ankara, 1977, pp. 120-150.

Öktem S, Menkü A: Spinal Neuroendoscopy. Aksoy K, Palaoğlu S, Pamir N, Tuncer (Eds). Basic Neurosurgery. Ankara, Buluş, 2005, pp. 1021-1025.

Öktem İS, Kamaşak K, Doğu Y: Head Trauma. Sözüer E, İkizceli İ (Eds), Trauma Handbook. Nobel Bookstore, Adana, 2011, pp. 451-491.

Öktem İS: Cranial Dermal Sinus. Baykaner MK, Erşahin Y, Mutluer MS, Özek MM (Eds), Pediatric Neurosurgery. Ankara, Buluş, 2014, pp. 361-364.

Öktem İS: Mechanism and Pathophysiology of Head Trauma. Baykaner MK, Erşahin Y, Mutluer MS, Özek MM (Eds), Pediatric Neurosurgery. Ankara, Buluş, 2014, pp. 689-695.

Öktem İS: Pathophysiology and Biomechanics of Pediatric Spinal Trauma. Baykaner MK, Erşahin Y, Mutluer MS, Özek MM (Eds), Pediatric Neurosurgery. Ankara, Buluş, 2014, pp. 749-754.

Şahin A, Öktem İS: Neural Tube Defects. Küçük A (Ed), General Neurosurgery Textbook. Kimlik Publishing, Kayseri, 2022, pp. 69-84.

Durmuş NA, Öktem İS: Benign Intracranial Cysts. Küçük A (Ed), General Neurosurgery Textbook. Kimlik Publishing, Kayseri, 2022, pp. 85-98.

Şahin A, Öktem İS: Craniosynostosis. Küçük A (Ed), General Neurosurgery Textbook. Kimlik Publishing, Kayseri, 2022, pp. 122-133.

Durmuş NA, Öktem İS: Hydrocephalus. Küçük A (Ed), General Neurosurgery Textbook. Kimlik Publishing, Kayseri, 2022, pp. 137-159.

Şahin A, Öktem S: How to Perform Ventriculoperitoneal Shunt Surgery? Avcı E (Ed), Basic Neurosurgery, Ankara, Buluş, 2023, pp. 1917-1923.

Contribution as a Special Issue Editor in a Journal (National)

Editor of the Special Issue on Neurosurgery-Hydrocephalus, Türkiye Klinikleri, Vol. 5, Issue 1, 2015.

Contribution as a Book Editor (National)

Basic Neurosurgery, Turkish Neurosurgery Association Publications, No:29, Pediatric Neurosurgery Section Editor, 2023.

EDUCATION, ADMINISTRATIVE, AND SCIENTIFIC ACTIVITIES

I- Invited Speaker

A- At National Congresses, Conferences, and Symposiums

May 11-12, 1996: Erciyes University Faculty of Medicine, Department of Emergency Medicine, and Kayseri Health Directorate, "Postgraduate First Aid and Emergency Course," Kayseri.
October 9, 2000: Workshop on "Navigation Applications in Neurosurgery," Erciyes University Faculty of Medicine, Neurosurgery Department, Kayseri.
April 4, 2002: Erciyes University Faculty of Medicine / Postgraduate Education Program
Panel: Neural Tube Defects
- Prof. Dr. M. Adnan Öztürk
- Assoc. Prof. Dr. Suat Öktem
- Asst. Prof. Dr. Deniz Demirci
- Asst. Prof. Dr. M. Hakan Poyrazoğlu
January 23, 2003: Erciyes University Faculty of Medicine / Postgraduate Education Program
Panel: Complications of Sinusitis
- Prof. Dr. Yaşar Ünlü
- Assoc. Prof. Dr. Suat Öktem
September 25-28, 2003: IV. Regional Trauma and Emergency Surgery Congress
Interactive Panel: Current Approaches to Multi-Trauma Patients
- Moderator: Prof. Dr. Recep Güloğlu
- Prof. Dr. Ali Baktır
- Assoc. Prof. Dr. Fahri Oğuzkaya
- Assoc. Prof. Dr. Suat Öktem
- Asst. Prof. Dr. İbrahim İkizceli
April 13-17, 2005: 13th National Neonatology Congress, Kayseri
Panel: Post-Hemorrhagic Hydrocephalus
- Prof. Dr. Nihal Oygür
- Prof. Dr. Barboros Ilıkkan
- Assoc. Prof. Dr. Suat Öktem
April 27-30, 2005: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
Pediatric Neurosurgery Training Course III Term - II Course, Kayseri
- Topic Presented: Visual Pathway Tumors
April 27-30, 2005: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
Pediatric Neurosurgery Training Course III Term - II Course, Kayseri
- Topic Presented: Neuronavigation
June 14-17, 2005: National Trauma and Emergency Surgery Association – Erciyes University Faculty of Medicine
40th Trauma and Resuscitation Course, Kayseri
- Topic Presented: Head Trauma
December 13-16, 2005: National Trauma and Emergency Surgery Association
Standard Trauma and Resuscitation Course
- Topic Presented: Head Trauma
April 6-9, 2006: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
Pediatric Neurosurgery Training Course III Term - III Course, Malatya
- Topics Presented:
  - Post-Traumatic Epilepsy / Carotid Cavernous Fistula
  - Cranial Tuberculosis Infections
May 15-18, 2006: National Trauma and Emergency Surgery Association
Standard Trauma and Resuscitation Course
- Topic Presented: Head Trauma
December 5-8, 2006: National Trauma and Emergency Surgery Association
Standard Trauma and Resuscitation Course
- Topic Presented: Head Trauma
April 5-8, 2007: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
Pediatric Neurosurgery Training Course, Mersin
- Topics Presented:
  - General Overview of Spinal and Cranial Dysraphism
  - Shunt Systems
April 20-24, 2007: Turkish Neurosurgery Association Scientific Congress, Antalya
Panel: Advances in Cranial Neuroendoscopy
- Speakers:
  - Prof. Dr. Yusuf Erşahin
  - Assoc. Prof. Dr. Ağahan Ünlü
  - Assoc. Prof. Dr. Suat Öktem
December 4-7, 2007: National Trauma and Emergency Surgery Association
Standard Trauma and Resuscitation Course
- Topic Presented: Head Trauma
May 25-27, 2007: 2nd Hydrocephalus Symposium, Izmir
- Topic Presented: Treatment of Intraventricular Hemorrhage in Premature Infants
- Panel: How Do I Place a Ventriculoperitoneal Shunt?
  - Assoc. Prof. Dr. Suat Öktem
  - Assoc. Prof. Dr. Çağatay Önal
  - Assoc. Prof. Dr. Ağahan Ünlü
  - April 3-6, 2008: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
    Pediatric Neurosurgery Training Course IV Term - I Course, Antalya
    Topic Presented:
    - Spinal Dysraphism and Neuroendoscopy Applications
  - May 7-10, 2008: 2nd National Trauma and Emergency Surgery Congress, Kayseri
    Panel: Current Approaches to Spinal Trauma
    - Assoc. Prof. Dr. Suat Öktem
    - Prof. Dr. Haluk Yalçınkaya
    - Assoc. Prof. Dr. Osman Akpinar
  - October 21-23, 2008: 8th National Neurosurgery Congress, Ankara
    Panel: Cranial and Spinal Tumors in Children
    - Prof. Dr. Recep Güloğlu
    - Prof. Dr. Savaş Aydar
    - Assoc. Prof. Dr. Suat Öktem
  - May 18-21, 2010: National Trauma and Emergency Surgery Association
    Trauma and Resuscitation Course
    Topic Presented:
    - Head Trauma and Neurosurgical Approaches
  - October 10-14, 2010: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
    Pediatric Neurosurgery Training Course, Antalya
    Topic Presented:
    - Spinal and Cranial Dysraphism and Current Approaches
  - November 23-26, 2011: National Trauma and Emergency Surgery Association
    Trauma and Resuscitation Course
    Topic Presented:
    - Spinal Trauma and Surgical Approaches
  - April 23-26, 2013: 4th National Pediatric Neurosurgery Congress, Kayseri
    Panel: Cranial and Spinal Tumors in Children
    - Prof. Dr. Recep Güloğlu
    - Assoc. Prof. Dr. Suat Öktem
  - December 4-7, 2013: National Trauma and Emergency Surgery Association
    Trauma and Resuscitation Course
    Topic Presented:
    - Cranial and Spinal Trauma
  - May 19-21, 2015: Turkish Neurosurgery Association / Pediatric Neurosurgery Group
    Pediatric Neurosurgery Training Course, Kayseri
    Topic Presented:
    - The Role of Neuroimaging in Pediatric Neurosurgery
  - April 27-30, 2017: National Pediatric Neurosurgery Congress, Antalya
    Panel: Advances in Cranial and Spinal Surgery
    - Prof. Dr. Yusuf Erşahin
    - Assoc. Prof. Dr. Suat Öktem
  - November 5-8, 2019: National Trauma and Emergency Surgery Association
    Advanced Trauma and Resuscitation Course
    Topic Presented:
    - Management of Multi-Trauma Patients
  - December 10-13, 2020: National Pediatric Neurosurgery Congress, Antalya
    Panel: Pediatric Cranial and Spinal Surgery
    - Assoc. Prof. Dr. Suat Öktem
    - Prof. Dr. Şahin Gürlek
  - Asst. Prof. Dr. Adnan Dağçınar
  - Congress Organizing Committee
    
    Prof. Dr. Aydın Paşaoğlu Neurosurgery Days-I
    March 02-03, 2018, Kayseri
    
    Organizing Committee:
    Prof. Dr. Ali KURTSOY
    Prof. Dr. Ahmet SELÇUKLU
    Prof. Dr. İ. Suat ÖKTEM
    Prof. Dr. R. Kemal KOÇ
    Assoc. Prof. Dr. Abdulfettah TÜMTÜRK
    Assoc. Prof. Dr. Ahmet KÜÇÜK
    Asst. Prof. Dr. Halil ULUTABANCA
    
    Prof. Dr. Aydın Paşaoğlu Neurosurgery Days-II
    April 20, 2019, Kayseri
    
    Organizing Committee:
    Prof. Dr. Ali KURTSOY
    Prof. Dr. Ahmet SELÇUKLU
    Prof. Dr. İ. Suat ÖKTEM
    Prof. Dr. R. Kemal KOÇ
    Assoc. Prof. Dr. Abdulfettah TÜMTÜRK
    Assoc. Prof. Dr. Ahmet KÜÇÜK
    Asst. Prof. Dr. Halil ULUTABANCA
    
    Turkish Neurosurgery Association Scientific Congress
    September 30 - October 03, 2021, Belek, Antalya
    Congress Organizing Committee / Congress Secretary
    
    Turkish Neurosurgery Association Scientific Congress
    November 24-27, 2022, Belek, Antalya
    Congress Organizing Committee
    
    Turkish Neurosurgery Association Scientific Congress
    April 27-30, 2023, Belek, Antalya
    Congress Organizing Committee
    
    V- Theses Supervised
    
    A- Doctorate
    - Timing of ventriculoperitoneal shunt application in myelomeningocele
      Dr. Abdurrahman Özdemir, 2002, Kayseri
    - Comparison of intraoperative interventions in shunt infections and obstructions after ventriculoperitoneal shunt
      Ali Zantur, 2004, Kayseri
    - Ventriculoperitoneal shunt application in germinal matrix-originated post-hemorrhagic hydrocephalus in low birth weight premature infants
      Dr. Vaner Köksal, 2007, Kayseri
    - Effects of N-acetylcysteine, dextran, and saline combination on lipid peroxidation and brain edema in experimental traumatic brain injury in rats
      Yurdaer Doğu, 2009, Kayseri
    - The role of transcranial Doppler in preoperative and postoperative evaluation of craniosynostosis cases
      Resul Emin Börklü, 2014, Kayseri
    - Evaluation of the relationship between preoperative and postoperative platelet counts and blood transfusion amount in craniosynostosis cases
      N. Alper Durmuş, 2020, Kayseri
    Main Research Works
    
    Öktem İS, Akdemir H, Koç K, Menkü A, Tucer B, Selçuklu A, Turan C: Migration of abdominal catheter of ventriculoperitoneal shunt into the scrotum. Acta Neurochir 140:167-170, 1998
    
    Öktem İS, Akdemir H, Kurtsoy A, Koç RK, Menkü A: Hemilaminectomy for the removal of spinal lesions. Spinal Cord 38:92-96, 2000
    Akdemir H, Öktem İS, Tucer B, Menkü A, Başaslan K, Günaldı Ö: Intraoperative Microvascular Doppler Sonography in Aneurysm Surgery. Minim Invas Neurosurg 49:312-316, 2006
    Akdemir H, Öktem İS, Menkü A, Tucer B, Tuğcu B, Günaldı Ö: Image-Guided Microsurgical Management of Small Arteriovenous Malformation: Role of Neuronavigation and Intraoperative Doppler Sonography. Minim Invas Neurosurg 50:163-169, 2007
    Öktem İS, Menkü A, Özdemir A: When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus?. Turkish Neurosurg 18:387-91, 2008
    
    Other Official Activities
    President of the Administrative Board of Erciyes University Faculty of Medicine
    October 24, 2005 - September 10, 2008
    
    Administrative Roles
    Vice Chief Physician of Erciyes University Faculty of Medicine Hospitals
    August 24, 2004 - September 10, 2008
    
    Chair of the Neurosurgery Department at Erciyes University Faculty of Medicine
    2006-2009, 2014-2015, 2019-2024
    
    Faculty Council Member (Professor Representative), Erciyes University Faculty of Medicine
    2011-2014, 2014-2017
    
    Executive Board Member (Professor Representative), Erciyes University Faculty of Medicine
    2011-2014
    
    Speaker, Session Chair, or Attendee at Congresses, Conferences, Symposiums, Courses, and Other Scientific Meetings
    - 1996 Turkish Neurosurgery Association Scientific Congress
    - International Bakırköy Days
    - 1996 Post-Graduation First Aid and Emergency Course
    - 1997 Turkish Neurosurgery Association Scientific Congress
    - 1998 Turkish Neurosurgery Association Scientific Congress
    - 1998 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 1998 Turkish Neurosurgery Association Autumn Symposium
    - 1999 World Federation of Neurosurgical Societies Course
    - 2000 "Navigation Applications in Neurosurgery" Workshop, Erciyes University Faculty of Medicine Neurosurgery Department, Kayseri
    - 2001 World Federation of Neurosurgical Societies, Australasia
    - 2002 Erciyes University Faculty of Medicine/Post-Graduation Education Program
    - 2003 Erciyes University Faculty of Medicine/Post-Graduation Education Program
    - 2003 Hacettepe University Continuing Medical Education Events
    - 2003 Regional Trauma and Emergency Surgery Congress
    - 2003 Turkish Neurosurgery Association, Pediatric Neurosurgery Group, Three-Year II. Education Course (2nd time)
    - 2004 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2004 Erciyes University, Faculty of Medicine, Medical Education Department "Educational Skills Course," Kayseri
    - International Symposium on Microneurosurgical Anatomy
    - 2005 Turkish Neurosurgery Association Scientific Congress
    - 2005 National Neonatology Congress
    - 2005 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2005 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course, Course Director
    - 2005 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course I
    - 2005 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course II
    - 2006 Turkish Neurosurgery Association Scientific Congress
    - 2006 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2006 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course
    - 2006 Turkish Neurosurgery Association (Trauma and Intensive Care) Symposium
    - 2007 Turkish Neurosurgery Association Scientific Congress
    - 2007 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2007 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course
    - 2007 Hydrocephalus Symposium, İzmir
    - 2007 Gevher Nesibe Medical Days
    - 2008 Turkish Neurosurgery Association Scientific Congress
    - 2008 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2008 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course I
    - 2008 National Trauma and Emergency Surgery Association Trauma and Resuscitation Course II
    - 2009 Turkish Neurosurgery Association 23rd Scientific Congress
    - 2009 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2008 Turkish Neurosurgery Association Teaching and Education Summit
    - 2009 Nervous System Surgery Association Scientific Congress
    - 2009 Turkish Neurosurgery Association Teaching and Education Summit
    - 2010 Turkish Neurosurgery Association Scientific Congress
    - 2010 Turkish Neurosurgery Association / Pediatric Neurosurgery Group
    - 2010 Turkish Neurosurgery Association Stereotactic Workshop
    - 2010 Turkish Neurosurgery Association Teaching and Education Summit
    - 2010 Pediatric and Adolescent Neurology Spring Symposium
    - 2011 Turkish Neurosurgery Association Scientific Congress
    - 2011 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2012 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2013 Turkish Neurosurgery Association Scientific Congress
    - 2013 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2013 International Society for Pediatric Neurosurgery, Mainz – Germany
    - 2013 Traffic Safety Seminar
    - 2014 Turkish Neurosurgery Association Scientific Congress
    - 2014 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2015 Turkish Neurosurgery Association Scientific Congress
    - 2015 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2015 Turkish Neurosurgery Academy I. Meeting
    - 2015 International Society for Pediatric Neurosurgery, İzmir – Turkey
    - 2016 Turkish Neurosurgery Association Scientific Congress
    - 2016 Turkish Neurosurgery Academy 2nd Meeting
    - 2016 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2016 Turkish Neurosurgery Association Basic Neurosurgery Course
    - 2017 Turkish Neurosurgery Association Scientific Congress
    - 2017 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2017 Turkish Neurosurgery Academy 3rd Conference
    - 2017 Turkish Neurosurgery Association SPSCG Winter Meeting
    - 2017 Turkish Neurosurgery Association TURNOG Workshop
    - 2018 Turkish Neurosurgery Association Scientific Congress
    - 2018 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2018 Prof. Dr. Aydın Paşaoğlu Neurosurgery Days – I
    - 2018 Turkish Neurosurgery Academy 4th Conference
    - 2019 Turkish Neurosurgery Association Scientific Congress
    - 2019 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2019 Prof. Dr. Aydın Paşaoğlu Neurosurgery Days – II
    - 2019 Turkish Neurosurgery Academy Scientific Conference
    - 2020 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2022 Turkish Neurosurgery Association Scientific Congress
    - 2022 Turkish Neurosurgery Academy Academic Writing Education Course
    - 2023 Turkish Neurosurgery Association Scientific Congress
    - 2023 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course
    - 2024 Turkish Neurosurgery Association Scientific Congress
    - 2024 Turkish Neurosurgery Association / Pediatric Neurosurgery Education Course

WHAT IS SECONDARY INFERTILITY?

View Details

In some cases, it is not enough if only the reproductive system is healthy for pregnancy to occur. Along with the reproductive system, it is extremely important for the pregnancy process that many factors work in harmony with each other. Depending on the factors that affect the process, pregnancy may not occur in people. This condition can also be observed if the person has already become pregnant or had a healthy birth.

Infertility, which occurs as a result of a couple having regular sexual intercourse for 12 months and not being able to get pregnant even though they are not using a method of protection, can be seen in two different ways. Never before pregnancy occurs when primary infertility; a live birth or not, regardless of if at least one pregnancy occurred, secondary (secondary) infertility is defined as.

You can continue reading our article about what is secondary infertility, what are its causes, important risk factors and treatment topics.

Causes of Secondary Infertility

Secondary infertility can occur due to both of the couples. The causes of secondary male infertility; the presence of varicose veins in sperm vessels, known as varicocele, infections, traumas and testicular tumors can be listed in the form of. The causes of secondary infertility in women are causes such as differences in ovulation patterns, damage or blockage of the tubes, deterioration of the structure of the uterus, and cervical and cervical cancer, especially as age progresses.

Autoimmune diseases and sexually transmitted diseases are also among the causes dec lead to secondary infertility.

In order to determine which of the many factors considered to cause the development of secondary infertility in people and to make appropriate planning, the couple should consult a specialist physician.

Risk Factors for Secondary Infertility

One of the most curious points about secondary infertility is the risk factors of secondary infertility. Many risk factors can cause the development of secondary infertility in people. These factors;

• Progression of age

• Different disorders such as polycystic ovary syndrome

* Excess weight

• Previous miscarriages

* Stress

* Alcohol, smoking and substance use

It can be sorted as follows. Along with all this, various factors that may differ from person to person can also lead to the development of secondary infertility in people.

Treatment of Secondary Infertility

The causes of secondary infertility, which are an obstacle to a person's conception, can be studied in an extremely wide range. For this reason, first of all, the points that prevent a person from becoming pregnant should be determined by taking into account different factors and an appropriate treatment plan should be developed accordingly. As a result of the evaluations made by taking the patient's history, vaccination and IVF treatments may be recommended to support conception. In order to determine the condition, specific infertility tests can be administered to people after a physical and pelvic examination. The ovulation test and other hormone tests are some of them.

As Huma IVF center, we continue to be with you in this process with our expert staff. For all the questions you have in mind, you can contact us by checking out our experts on our website.

What Is insemination? How Is It Done?

View Details

There are 2 treatment methods most commonly preferred by couples who want to have a baby but do not have a baby for various reasons. One of them is in vitro fertilization treatment and the other is insemination method. In our article, we will try to answer the most frequently asked questions about the vaccination method, what is insemination and how it is done.

What is insemination?

If couples cannot get a pregnancy result after one year after unprotected sexual intercourse, infertility is diagnosed. Infertility can have many causes, depending on the woman and the man. Thanks to science and developing technology, there are now many treatment methods for infertility. One of these methods is the vaccination method. In its simplest form, the method of vaccination is to prepare the sperm in the laboratory and inoculate the woman's uterus at the time of ovulation to ensure fertilization. In order for the vaccination method to be performed, some tests must be done to make sure that there is no problem in the uterus of the expectant mother. In addition, at least one of the tubes of the expectant mother must be in working condition. The purpose of the vaccination method is to select the motile, normal sperm with a higher probability of fertilization and send them to the uterus of the expectant mother. Thus, it will be more likely to be fertilized with eggs and selected sperm supported by drugs or pills.

How is insemination done?

Before the insemination method, the development of the egg is supported with pills or low-dose injections given to the expectant mother. During this process, the egg is tracked. When the eggs mature and reach certain sizes, a cracking needle is given and the eggs are cracked. Just at this time of cracking, the sperm prepared in the laboratory are transferred to the uterus. Thus, the most suitable time of ovulation is provided for the woman and the best sperm are transferred to the uterus at the right time. insemination is a natural method. Only sperms that will increase the probability of fertilization are carefully selected. From the sperms taken from the father-to-be, those that are of good quality, motile and washed in a certain number, that is, processed. As Hüma IVF Center team, we tried to give information about what is insemination and how it is done in our article. We hope it was useful. You can contact us via our website to get more detailed information about IVF treatment or to ask your questions.

WHAT IS INTRALPID SERUM TREATMENT? WHO IS APPLIED?

View Details

WHAT IS INTRALPID SERUM TREATMENT? WHO IS APPLIED?

Intralipid serum therapy emerges as a form of treatment applied to women who want to become pregnant but cannot achieve this goal as a result of recurrent IVF failures. It is extremely important that the immune system is strong during IVF treatment. Intralipid serum therapy is a method used at this point to strengthen the immune system.

Intralipid serum treatment is started to be applied to women who want to become pregnant before starting IVF treatment. What are the details of intralipid treatment? Who is intralipid serum therapy applied to? How is intralipid serum therapy applied? Now we will be giving answers to all these questions for you below.

What is Intralipid Therapy?

Intralipid serum therapy is a treatment for women who want to become mothers. Intralipid serum is a treatment method that starts on the day of transfer and continues throughout the process in IVF treatment. Intralipid serum contains many important proteins and molecules for the immune system. Thanks to this serum, it is aimed to keep the immune system of the expectant mother strong during pregnancy by supporting the immune system.

To Whom Is Intralipid Serum Treatment Applied?

Intralipid serum therapy is a treatment for women who want to become mothers, but only for those who have experienced miscarriage problems or who have experienced IVF failures. The purpose of this treatment is to ensure that the immunity of the expectant mother remains strong throughout the pregnancy process.

As a result of the information obtained, it has been proven that intralipid serum therapy does not have any side effects. However, some women may be allergic to the substances in the intralipid serum. At this point, good research should be done before starting the treatment and if there is no allergic condition, treatment should be applied.

How is Intralipid Serum Treatment Applied?

Parents who want to have a child can resort to many ways for pregnancy to occur. In vitro fertilization, which has been very popular recently, has been determined as the most successful assisted reproductive method. If there are recurrent failures as a result of IVF treatment, this problem can be eliminated with intralipid serum treatment. Intralipid serum therapy is an extremely effective and successful form of treatment.

Intralipid serum treatment is administered to the expectant mother by intravenous route, with a preparation containing emulsified oil, prepared with a special concentration, which takes approximately 45 minutes. In other words, the patient's immune system is supported by giving oily serums intravenously.

In this article, we have given detailed explanations about inralipid serum therapy and that parents can receive intralipid serum treatment in cases where pregnancy does not occur due to some reasons. If you want to have more detailed information on this subject, you can visit https://www.humatupbebek.com/.

WHAT IS THE SPERMIOGRAM TEST FOR ANALYSIS OF SPERM CELL?

View Details

Parents who want to have children generally prefer the most common in vitro fertilization treatment. Before this treatment, both mother-to-be and father-to-be go through many tests. Father-to-be passed; The first of the tests to test for infertility or other problems is the sperm test, also known as the spermiogram test. What is the spermiogram test for the analysis of the sperm cell? How is spermiogram done? What do spermiogram test results mean? We will answer all these questions for you in detail below. We recommend that you continue reading our article to have detailed information about the sperm test.

What is a test (spermiogram)?

Sperm test done to men; It is a test to determine sperm health, sperm count, and whether the sperm are moving correctly in the channels. As a result of the sperm test, if the sperm shape is normal and there is a sufficient number of sperm, it is concluded that your reproductive ability is high. However, in some cases, men may have low sperm count or the ability to reproduce despite having abnormal semen. That's why doctors order a second test for the accuracy of the results. If your results are normal in your first sperm test, you give the other test and if it is normal, these two normal tests show that you do not have an infertility problem. If there are different conditions, your doctor may order other tests.

If there is no semen or sperm as a result of the sperm test, this may indicate that your ducts are blocked. If this is the case, your doctor will plan different surgeries to open the channels.

Issues and Precautions to Consider While Giving Sperm Sample

There are important points to be considered before giving the sperm sample and while giving the sperm sample. Among the things to be considered before giving a sperm sample, we can count that "men should abstain from sexual intercourse for 3 days". Fasting for 3 to 5 days is sufficient. These numbers are important because if you fast for less than 3 days, the sperm count may be low as a result of the sperm test. For this reason, we can say that fasting between 3 and 5 days is sufficient. It is possible to list the issues to be considered while giving a sperm sample as follows;

· Storing the sample in a sterile environment: It is important to protect your sample from the outside environment for a healthy and accurate spermiogram test result. If a sterile environment is not provided, the test result may be inaccurate. Therefore, do not put your hands, especially sample containers, etc. It is important that you keep it as sterile as possible.

· Protecting the delivered sperm from heat: Another important point is to keep your sample away from extreme temperature changes after ejaculation. Because these extreme temperature changes negatively affect spermatozoa. Ideal temperatures for the sample cup should be between 20°C and 37°C.

· Sperm volume, amount: Volume is extremely important in the sperm test. Your sperm volume is expected to be at least 1.5 ml. The reason why you cannot reach the lower limit of 1.5 ml may be external discharge during ejaculation. It is important to be careful about this.

· Use of lubricating foreign substances during the sperm test: It is important not to use any lubricant during the sperm test because these substances seriously affect the sperm parameters. External factors with such an impact can lead to wrong conclusions.

How is the Sperm Test Done?

For the sperm test, you must first be at the IVF center or hospital. There are rooms specially prepared for men in hospitals or IVF centers. In these rooms, men give their sperm in a special container. For the effectiveness of the sperm test, the sperm sample is immediately delivered to the laboratory. The sperm sample given in the laboratory is subjected to many processes and the best quality sperms are selected. The purpose of the procedures is to examine the sperm count, motility and shape in the semen and to reach quality sperm as a result.

Apart from the hospital, sperm samples can be placed in a container and brought to the hospital in the home environment. However, this is highly not recommended. Even if this is accepted, the sperm samples should be brought to the hospital and delivered within half an hour.

Issues and Precautions to Consider When Analyzing Sperm Sample

After the sperm test is given by the prospective fathers, it is examined in the laboratory environment. This examination takes approximately 1-2 hours and after the first hour, active results begin to be obtained. However, sometimes different situations can be encountered. For example, the test is given, but no sperm can be seen when looked at. In these cases, sperm are taken again and centrifuged. When faced with such a situation, the time may be extended. If there is no additional test to be done, the test results are immediately available in an average of 1-1.5 hours.

What Do Sperm Test Results Mean?

Sperm test results can be evaluated in many ways. Sperm analysis evaluates the sperm by analyzing it from various aspects. We can list these analyzes as follows:

· Sperm count and density:

Sperm count describes the number of sperm in 1 ml of semen. The World Health Organization advocates that a normal sperm count should be at least 15 million per ml or at least 39 million per sample. Having fewer sperm than these numbers indicates a low sperm count.

· Sperm morphology:

Non-abnormal sperm have a long tail and oval head. Morphology refers to the size and shape of the sperm a person has. Sperm that do not have a normal size or are weak in shape have difficulty reaching the egg and fertilization.

· Sperm motility:

The ability of sperm to move efficiently is one of the most important factors for fertilization.

· PH level of sperm:

When the pH level is too high or too low, it can affect the health of sperm and its ability to pass through the female reproductive tract.

Apart from these, sperm health is examined by looking at many factors such as semen volume, liquefaction, and seminal fructose levels while performing the sperm test. After examining all factors in detail, the results are examined and reported to the patient.

What is the Sperm Test Result of a Healthy Individual?

Low sperm count can have many different causes. The first reason is smoking addiction. Smoking addiction is one of the important factors that reduce the sperm count. In addition to smoking, alcohol and drug addiction also affect sperm count. Sperm count can also be adversely affected when there is a deficiency in hormones, depending on the clogged ducts.

Hormones are one of the important factors for reproduction on their own. Since the deficiency in reproductive hormones directly affects sperm production, it increases the possibility of encountering problems in reproduction. Apart from these, mistakes made by couples who want to have children also affect the sperm count. Using natural products unconsciously and continuing to use them uncontrollably, without knowing the limit, does harm to the person instead of providing benefits. Long-term treatment and drugs used during the treatment also affect the sperm count.

IMSI in Sperm Selection

The IMSI (Intracytoplasmic Morpholgically Selected Sperm Injection) method is the magnification and examination of even the smallest cells using special microscopes. In the past, in the microinjection procedures applied in IVF treatments, living sperm cells could be enlarged up to 400 times. However, with IMSI, sperm can now be enlarged between 6000 and 8000 times. It is possible to examine and detect in detail the disorders called "vacuoles" that indicate the intracellular structures of the sperm and their genetic damage.

The IMSI technique is an extremely useful method. Selected sperm injection; It allows advanced morphological analysis of sperm without damaging the living sperm cell. Sperm with the highest fertilization ability are selected and a high chance of fertilization between 20% and 40% can be obtained with the applied microinjection application.

Precautions to be Considered for Sperm Quality

Couples who want to have children should pay attention to egg and sperm health and be careful in this regard. There are many factors that affect sperm quality, such as those that affect egg quality. One of these factors is undoubtedly a healthy diet. A healthy diet is extremely important for every organ in the body, of course also in sperm health.

In addition, exercise is very important in making you more vigorous and increasing your body's stamina and activity. Regular exercise will make you recover in a short time and will positively affect both your mental and physical health. Alcohol and smoking are substances that affect reproductive cells and should be avoided. This is a proven fact as a result of research. If we gather all these under one title, we can say that one should take care of his own health. Nutrition, avoiding alcohol, smoking, exercising regularly will first affect your health and therefore your sperm quality.

This process, which is sensitive and special for couples who want to have a child, is extremely important for them. In this process, prospective parents experience excitement on the one hand and a lot of stress on the other. Hüma IVF Center, which understands the emotions experienced best and does not spare its support by being by their side throughout the process, is always ready to accompany you.

WHAT IS BETA HCG? HOW MUCH BETA HCG VALUE SHOULD BE? WHAT DOES ITS LOW AND HEIGHT MEAN?

View Details

Beta HCG hormone is a hormone known as the pregnancy hormone among the people. It is used in pregnancy tests to determine whether the person is pregnant or not. Experts express the test to measure the beta HCG hormone in different ways. You may have heard of Beta HCG blood test, quantitative blood pregnancy test, quantitative HCG test, and quantitative serial Beta HCG test. In this article, we have brought together all the curious about Beta HCG. What should be the Beta HCG value? What does low or high Beta HCG mean? Read on for the answers to all these questions.

What is Beta HCG?

There are 2 types of HCG Hormone, Beta and Alpha. During the pregnancy test, the Beta hormone is examined and is called Beta HCG. Beta HCG hormone is secreted by the placenta with the occurrence of fertilization. A blood test is performed between 10 days and 14 days after fertilization, and a high value can be observed in Beta HCG hormone as a result of the blood test. After a day or two, a urine test is done and more precise data for pregnancy can be obtained. High beta hcg hormone does not only mean a sign of pregnancy. Depending on some diseases encountered in people, its level in the body may increase, this varies from person to person. For this reason, when a high level of Beta HCG hormone is detected, different tests are performed immediately and it is ensured whether pregnancy has occurred or not.

What Should Beta HCG Value Be?

In a healthy non-pregnant woman, Beta HCG hormone varies in the range of 0-10 mlU/ml. In fact, it is usually seen at values around 0 and 0. With pregnancy, these values increase. In other words, we can understand whether pregnancy exists or not from the height of this hormone.

What Does Low and High Beta HCG Mean?

Beta HCG elevation first suggests that the person is pregnant. Because pregnancy increases the Beta HCG hormone. This hormone may give false information in some periods. Especially if the person has a different ailment, for example; In cases such as gastritis, some types of pancreatic cancer, some stomach cancers, ovarian cancer, liver tumor, multiple pregnancy, high levels of this hormone can be detected. For this reason, it is not possible to understand that you are pregnant with this test alone. Afterwards, you must have different tests. In addition to these, it is possible to say that the foods eaten also affect this hormone. Foods high in progesterone such as dill, avocado, spinach, tomatoes and walnuts increase the Beta HCG value.

Beta HCG is usually 0 and close to 0 in normal, ie non-pregnant individuals. In individuals who are pregnant, the low level of this hormone may be due to many reasons. These; ectopic pregnancy, deviation in the calculation of the week of pregnancy, sudden miscarriages.

In this article, we have discussed the Beta HCG hormone in detail. We have made explanations for you by giving place to all the questions that are curious. For more, you can visit our Hüma IVF page.

WHAT IS THE INTRA-LIPID SERUM PROCEDURE AND HOW TO USE IT?

View Details

Serum Intralipid Therapy is a treatment used specifically to strengthen the immune system. The immune system plays a big role in the repeated IVF failures and recurrent miscarriages seen in some women. For this purpose, intralipid serum therapy is also used. This is a type of treatment that is started prior to IVF treatment and is applied once a week or every two weeks until the baby's heartbeat is heard, if deemed necessary after pregnancy is achieved. Now let's take a closer look at intralipid serum treatment together ...

What is Intralipid Serum Therapy?

https://lh4.googleusercontent.com/URNl_sRR4-EwSLpzm2aN509s7rTtcJSn_0VFVYSqo9uwzHLXUM7udO2E4GACGbyloRa3rfkzj5bPcPkNX---UZM1I5vMwmlgbdtmEg8ox_zPQYON693heS3Jf5-78XNgDqoW6_c7

Intralipid serum therapy is a form of treatment that starts on the day of the transfer and continues throughout the process. Intralipid whey contains fat molecules and soy protein, which strengthens the immune system. The immune system is extremely important for a healthy pregnancy and its continuation. Because half of the child belongs to the father, the mother's body does not reject it. In vitro fertilization failure also occurs in case of rejection, but intralipid therapy can prevent this failure.

For whom and how is intralipid serum treatment applied?

https://lh3.googleusercontent.com/9rdDsOr5TvK74aY1JEBhpptBFtR9DKwl99CgnMeqh4-GsQuNkAIajzvGvfesv31kuWQxl-sLxV33JTKz0nVHzICiL--hzWg_iWSFCnRVTvMHEeSz4muJOgkPL9xHgXbisSxUMWuz

Intralipid Serum Therapy is an immune-boosting treatment that is commonly used in women with recurrent miscarriage problems and recurrent IVF failures. As a result of studies, it was found that treatment with intralipid serum does not have side effects. Only women can be allergic to some substances in the serum of intralipid, in which case this should be determined in advance. These substances are a number of special ingredients such as glycerin, egg phospholipids. It is preliminarily checked whether the patient is allergic to these substances. If the patient has an allergy, treatment is not applied.

Intralipid whey treatment is carried out with a preparation containing emulsified oil prepared with a special concentration, which takes approximately 45 minutes. Fatty sera are administered to the patient intravenously.

In this article: what is serum intralipid therapy, who is this treatment for, how is intralipid therapy used? We have answered all these questions for you. If you want to get more detailed information about this, we recommend that you visit the website of the HUMA center.

What is infertility, what are its symptoms, what kind of treatment method is applied?

View Details

What is infertility, what are its symptoms, what kind of treatment method is applied?

Infertility, as it is called in the medical literature, is one of the most important health problems affecting millions of people around the world. In addition to being a health problem that can be seen in women and men, today the number of couples who cannot have children is quite high. According to researches, 10-15% of couples who have unprotected sexual intercourse for a year cannot have a child.

In our article, about infertility, one of the most important health problems in the world; We will try to give short answers about what is infertility, what are the symptoms of infertility and how to apply the treatment method.

What is infertility?

According to the definition of the World Health Organization, infertility; “Failure to conceive within one year of a sexually active couple who had unprotected intercourse without using contraception.” is the status. In other words, in order to be able to talk about infertility exactly, couples must have unprotected intercourse for one year and be unable to conceive. Infertility is one of the important health problems affecting 25% of the world population. In the researches, it can be seen depending on the woman or the man.

What are the symptoms of infertility?

The most important sign of infertility for both men and women is the inability to get pregnant despite having unprotected sexual intercourse for one year. However, some symptoms seen in men and women can be seen as a sign of infertility and an examination may be required accordingly.

infertility in women;

- Imbalances in the menstrual cycle can be considered as a symptom. If you have periods longer than 35 days or shorter than 21 days, you should definitely see a specialist.

- If you are in your 30s and younger, it is expected to get pregnant within 1 year.

- If you are in your 35s and 40s, pregnancy is expected within 6 months. If pregnancy does not occur within 6 months, it is useful to see a doctor.

Infertility in men;

- Sexual dysfunctions are considered a sign of infertility. Example; impotence, ejaculation, such as strain.

- Pain, swelling or a lump in the testicle area during sexual intercourse may also be a sign of infertility.

- Infertility in men can often be caused by hormonal disorders.

Although all these symptoms are not exactly the cause of infertility, they are among the factors affecting it and may be symptoms of infertility.

What kind of treatment method is applied in infertility?

There can be many different reasons for the occurrence of infertility. Therefore, first of all, the causes of infertility are investigated. Different treatment methods are tried according to the detected cause. Some of the treatment methods applied are as follows;

- IVF Treatment

- Vaccination

- Microinjection

In vitro fertilization is one of the most well-known and most preferred and effective treatment methods among other treatment methods.

As Hüma IVF Center team, we tried to give information about what is infertility, what are its symptoms and what kind of treatment method is applied in our article. We hope it was useful. You can contact us via our website to get more detailed information about infertility or to ask your questions.

WHAT IS ADENOMYOSIS AND WHAT ARE THE CAUSES? WHAT IS THE RELATIONSHIP OF ADENOMYOSIS AND INfertility? WHAT IS ADENOMYOSIS TREATMENT?

View Details

Adenomyosis is a female disease that occurs in women, especially as age increases. Women with adenomyosis experience extremely painful, painful and excessive bleeding menstrual periods. This heavy menstrual period also affects the daily life of women with adenomyosis. In addition, it causes anemia. If you are experiencing these problems and want to know more about Adenomyosis, you can continue reading our article.

What is Adenomyosis?

The uterus contains an inner lining of the uterus called the endometrium. The task of this inner membrane is to limit the inner surface of the uterus. The inner membrane inside the uterus is renewed every month with the menstrual period and in some women it moves towards the uterine muscle layer. Adenomyosis occurs as a result of thickening of the inner membrane in the uterine muscle layer.

There are two types of adenomyosis: benign and malignant. It is a benign type that is usually seen in women, but some women may also have a malignant type that requires surgery and poses a risk.

Women with adenomyosis have difficult days during their menstrual periods. During this period, they may have to cope with excessive pain and excessive bleeding. Again, they may feel uncomfortable bloating before the menstrual period and may experience pain and pain during sexual intercourse.

What are the Causes of Adenomyosis?

Although the causes of adenomyosis disease in women are not known clearly, it is known that hormones such as estrogen, prolactin, and progesterone trigger this ailment. Apart from this, external interventions in cesarean deliveries, surgical cuts or inflammation of the inner lining of the uterus during birth trigger the cells that regulate the uterus to leave their borders and cause adenomyosis. Development-related adenomyosis can also be seen. During the developmental process, the endometrial accumulation formed between the muscles during the first formation of the fetus in the uterus may cause adenomyosis.

What is the Relationship Between Adenomyosis and Infertility?

The age at which adenomyosis is most common is people between the ages of 40 and 50. Adenomyosis is a female disease related to the uterus. For this reason, we can say that adenomyosis is directly related to infertility and pregnancy. Adenomyosis is a disease whose incidence increases with increasing age, so infertility and adenomyosis can be seen together when pregnancy is considered in older women. Expectant mothers who encounter this situation can achieve their dreams of having a child by trying the in vitro fertilization method after receiving adenomyosis treatment.

What is Adenomyosis Treatment?

Experts have done many studies to treat adenomyosis disease and as a result, they have found various treatment methods. We can talk about hormonal therapy as the first treatment method. With hormonal therapy, it is tried to relieve the pain caused by adenomyosis and to reduce the excess blood. For this, birth control pills, temporary menopause treatments or medicated spiral methods can be used. As a second method, we can consider MRI Focused Ultrasound. In MRI focused ultrasound treatment, high-intensity heat waves are used to destroy the tissue that causes adenomyosis. Another form of treatment is hysterectomy. This form of treatment is the most permanent solution, but because it results in the removal of the uterus, it is applied only to women who do not plan to have children or in severe cases that do not respond to any treatment.

In this article, we discussed adenomyosis, which is common in older women. What is adenomyosis, what are the causes of this disease, what is the relationship between adenomyosis and infertility, and what are the treatment methods for this disease, based on all these questions, we have made detailed explanations about adenomyosis for you. We wish you a pleasant reading. You can visit our website for more.

WHAT IS A REDUCED OVER RESERVE (AMH)?

View Details

Ovarian reserve, known as the ovary, is a term used to determine the fertilization ability of the ovary to provide egg cells and to determine the probability of a successful pregnancy. With the advancing age of the expectant mother, the number of egg cells obtained from the follicles for pregnancy decreases. decreased ovarian reserve (AMH); It is a condition in which the ovaries begin to lose their normal production capabilities, reducing fertility. Decreased ovarian reserve reduces women's chances of conceiving spontaneously or with treatment. However, it is aimed to minimize the effects of this situation with various methods. The main causes of decreased ovarian reserve can be listed as follows:

· Smoking,

Chronic diseases,

Coffee consumption

Age of the expectant mother,

Genetic abnormalities (X chromosome abnormalities)

Various treatments (such as radiation for cancer)

· Having undergone ovarian surgery.

You can continue reading our article for reduced ovarian reserve and all its details.

How to Identify Decreased Ovarian Reserve?

Decreased ovarian reserve is determined by examining the hormone tests to be performed on the 2nd or 3rd day of the menstrual period of the expectant mother. FSH hormone gives information about the status of ovarian reserves. If the FSH value is higher than 10, it indicates decreased ovarian capacity.

The best indication of the capacity of the ovaries is the vaginal ultrasound. Existing and developing egg structures can be easily detected here. If there are less than six egg structures in the total ovaries, decreased ovarian reserve may be in question.

In summary, decreased ovarian reserve; It can be understood by clinical evaluation of the person, vaginal ultrasound, measurement of AMH hormone and FSH hormone in the blood.

Can a Woman with a Decreased Ovarian Reserve Get Pregnant?

Existing studies show that women with reduced ovarian reserve can become pregnant both spontaneously and with IVF treatment. Although it has been shown that high serum FSH levels in women are associated with low pregnancy rates, it is not sufficient to make a decision based on this alone. Egg cells also regulate their size under the influence of genetic factors. The speed of the aging process of the ovaries varies greatly among women, except for the age factor. In addition to the successful results of endocrine tests and imaging methods in the numerical evaluation of ovarian reserve, their values in determining the chance of pregnancy remain at a limited level.

The chance of conceiving of a woman who is determined to have decreased ovarian reserve with ovarian reserve tests and clinical evaluations by specialist physicians can be increased by applying appropriate ovulation treatment protocols. Patients with reduced ovarian reserve can become mothers with different techniques today. In order to determine these methods, it is important to plan and apply special treatment methods suitable for patients by considering various factors.

How Is Decreased Ovarian Reserve Treated?

Currently, there is no treatment for decreased ovarian reserve that prevents or slows down ovarian aging. In addition, lifestyle changes have an extremely important role in preventing premature aging of the ovaries and in order to ensure the healthy continuation of egg quality, that is, to increase egg reserve and quality. These;

· Eating a balanced and healthy diet,

Doing regular exercise,

Quality and adequate sleep,

Avoiding chemicals, high glycemic index and fast food style foods,

Not to use substances such as cigarettes and alcohol,

· Using antioxidant drugs under the control of a physician.

If you have decreased ovarian reserve and want to have a child according to your required tests and vaginal ultrasound results, it is extremely important to seek in vitro fertilization treatment in the presence of a specialist doctor, without wasting time.

As Hüma IVF Center, we choose the most appropriate treatment method for you, apply it and continue to serve.

WHAT IS BLASTOCYST TRANSFER? WHAT ARE THE ADVANTAGES OF BLASTOCYST TRANSFER?

View Details

Blastocyst transfer, which is one of the advanced in vitro fertilization techniques applied today, is a method that offers a much higher chance of pregnancy to couples who want to have children. The blastocyst transfer method, which is a method that minimizes the possibility of multiple pregnancy, which is frequently encountered in IVF treatments, supports families in making their plans to have a child more effectively. The blastocyst is defined as the 5th or 6th day of the egg becoming an embryo. Before transfer, one or two embryos of the highest quality are selected and the transfer is carried out. This method is among the most important processes of IVF treatment. What is blastocyst transfer, what are its advantages and risks? You can continue reading our article, which includes the details of blastocyst transfer with questions.

What is blastocyst transfer?

Blastocyst transfer, which has an extremely important place in the IVF treatment process, is the process of transferring the embryo created in the laboratory environment to the woman on the 5th or 6th development day. Embryos are followed in incubators in the laboratory and when they reach the blastocyst stage, transfer to the uterus is performed. Blastocyst transfer has many positive contributions to the IVF process, such as enabling better quality embryo transfer and reducing the risk of multiple pregnancy.

What are the advantages of blastocyst transfer?

Blastocyst transfer is a method that has been used frequently in recent years, depending on the developing technologies. In the first years of in vitro fertilization treatment, the expected time for transfer was 48 hours, but this period has been extended in parallel with the developments experienced today. In the blastocyst transfer method, embryos with the highest success rate are selected more easily with transfers made after 5 and 6 days. In general, the advantages of blastocyst transfer can be listed as follows;

The chance to achieve better results against recurrent pregnancy failures, thanks to the selection of embryos with better development potential and compatibility with the uterus,

Reducing the possibility of multiple pregnancy by transferring fewer embryos with high viability,

The chance to observe the embryo development more clearly and healthily,

Freezing of embryos at the time when they have the highest developmental power, that is, at the blastocyst stage,

· Allowing different methods to examine embryo viability.

What is the risk of blastocyst transfer?

The condition that can be encountered frequently as a result of blastocyst transfer is the factor of multiple pregnancy. For this reason, some legal restrictions have been imposed on the number of embryos to be transferred in order to be protected from the risks of multiple pregnancy. For our country, this limit has been determined to be a maximum of 2 embryos. By performing 1 or 2 blastocyst transfers in embryo transfer on the 5th day, both the risk of multiple pregnancy is reduced and the chance of pregnancy is increased. The aim of IVF treatment is to achieve a healthy fertilization. In this direction, better quality but less number of embryo transfers will minimize the risks that may be encountered and will facilitate healthy results.

Who is blastocyst transfer suitable for?

Blastocyst transfer can be applied to all couples with a high number of fertilized eggs and good embryo quality on the 2nd day. Since a single embryo can be transferred in the first two attempts under the age of 35, a blastocyst transfer will be made to them, thus preventing multiple pregnancy. In our country, blastocyst transfer is successfully applied and high success rates are achieved. However, the remaining quality embryos after the transfer are successfully frozen with the vitrification method, which is a new and fast freezing technique, giving couples a second chance. You can visit our website for more information and to make an appointment.

WHAT IS MINI IVF? WHO IS APPLIED? WHAT ARE THE MEDICINES USED IN MINI IVF TREATMENT?

View Details

Recently, it has been revealed that egg quality obtained from patients with low reserve is lower and genetic problems in the embryo are higher. In this direction, it is aimed to create fewer but better quality embryos by obtaining higher quality eggs with less drugs. Mini IVF appears as a simplified in vitro fertilization practice, unlike the known in vitro fertilization practices performed with daily injections and high-dose drug use. Especially in patients with a low number of eggs or in advanced age, the success rates are higher than conventional treatments. What is mini IVF, who is it applied to and what are the drugs used in its treatment? You can continue reading our article for questions and all the details.

What is mini IVF?

Mini IVF is an in vitro fertilization application that enables the development of fewer but higher quality eggs by using lower doses of drugs. Eggs developed with this method are taken and fertilization is performed by applying the microinjection technique. Embryos formed after fertilization are transferred to the patient, assuming that the probability of attachment is higher.

In addition to the advantages such as less drug use, less cost and less time spent with mini IVF treatment, high success rates can be obtained in patients with a low number of eggs and advancing age.

Who is mini IVF applied to?

In cases where pregnancy does not occur naturally;

Those who want to use hormone drugs less,

At risk of developing OHSS (overstimulation of the ovaries),

Concerned about the daily injection process in IVF treatment,

Those who have problems in the fallopian tubes and are younger than 35 years old,

Having low egg reserve that cannot be increased with treatment,

Looking for a more economical solution than conventional treatment,

People who have tried many times in vitro fertilization but have not achieved a result, and

Mini IVF treatment can be applied to women who want to reduce the possibility of multiple pregnancy.

However, a treatment plan should be made by a specialist by listening to the patient's history of the disease, analyzing their expectations and performing health checks in detail.

What are the drugs used in mini IVF treatment?

Mini IVF treatment is a type of in vitro fertilization that uses little or no medication to increase and develop the number of eggs. In standard IVF treatments, hormone injections are made for 8-10 days to reproduce eggs, while these drugs are not used in the Mini IVF method. Oral tablets and very low dose hormone injections are used instead. With Mini IVF, which is a natural in vitro fertilization method, it is ensured that the highest quality eggs are produced by using the least amount of medication.

Mini IVF method is aimed to obtain better quality eggs with the use of low doses of drugs. At this point, it is possible to determine your treatment plan by consulting your doctor. You can visit our website for more information.

You may be interested in:

CALCIUM IONOPHORE THERAPY

View Details

Calcium ionophore therapy is a treatment method applied to ensure a healthy fertilization and to obtain a high pregnancy rate. In order to talk about a healthy fertilization, when the sperm enters the egg, the enzyme in the head part of the egg must be released into the egg and the amount of calcium inside must increase.

If the amount of folfolipase C in the sperm is low, the egg cannot be fertilized because without phospholipase, the calcium rate in the egg does not increase.

Calcium ionophore therapy is an application that increases the amount of calcium in the egg. In the calcium ionophore application, the egg and sperm are first fertilized by micro-injection. After this process, the eggs are kept in a calcium ionophore for a few minutes. The main purpose here is to increase the calcium level that needs to be increased in the egg. In other words, calcium ionophore therapy helps the fertilization of the egg by supporting the reactions that should start in the egg. So, what is calcium ionophore therapy and to whom is it applied? Now we will answer all these questions for you.

What is Calcium Ionophore? To Whom Is It Applied?

It is possible to define calcium ionophore therapy as an application that increases the amount of calcium in the egg. This treatment method is generally applied to the people we will list below. Those people;

Individuals with successive fertilization problems

If very few eggs or sperm are obtained

In cases where no fertilization can be achieved with micro-injection therapy

In patients with “globosperm” of all sperms

Calcium ionophore therapy is applied.

Who Is Fertilized With Calcium Ionophore?

In cases where embryo transfer cannot be performed due to the fertilization step not taking place during IVF treatment, activation of the eggs and fertilization are aimed by using calcium ionophore. Thus, calcium ionophore therapy is applied. With this treatment method, the problem of non-fertilization can be eliminated and treatment can be applied in couples who have non-fertilization problems. This treatment method is also applied to couples who have problems as a result of obtaining a very small amount of egg and sperm. Fertilization is performed with the calcium ionophore treatment method and a high pregnancy rate is obtained.

In this article, we have given the answers to all these questions for you, what is calcium ionophore therapy, to whom this treatment method is applied and in whom fertilization occurs as a result of the treatment.

It may interest you: What is infertility, what are its symptoms, what kind of treatment method is applied?

WHAT IS BETA HCG? WHAT SHOULD BE THE BETA HCG VALUE? WHAT DOES ITS LOWNESS AND HEIGHT MEAN?

View Details

The hormone beta HCG is a hormone that is popularly known as a pregnancy hormone dec It is used in pregnancy tests to determine whether a person is pregnant or not. Specialists express the test for measuring the hormone beta HCG in different ways. It is possible to hear it in the form of a beta HCG blood test, a quantitative blood pregnancy test, a quantitative HCG test, and a quantitative serial Beta HCG test. In this article, we have collected all the curiosities about Beta DECG. What should be the beta HCG value? What does it mean if the beta hCG value is low or high? For answers to all these questions, continue reading our article.

What is Beta HCG?

There are 2 types of the Hormone HCG - Beta and Alpha. When conducting a pregnancy test, the Beta hormone is examined and called Beta HCG. The hormone beta HCG is secreted by the placenta with the formation of fertilization. A blood test is performed dec 10 days and 14 days after fertilization, and as a result of the blood test, a high value of the hormone Beta HCG can be observed. After a day or two, a urine test is performed and clearer data for pregnancy can be obtained. The height of the hormone beta hcg means not only a sign of pregnancy. Depending on some diseases that are found in people, their level in the body may also increase, it varies from person to person. For this reason, when an increase in the Beta HCG hormone is detected, different tests are also performed immediately and it is made sure that the pregnancy does not occur.

What Should Be the Beta HCG Value?

In a healthy woman who is not pregnant, the hormone December HCG varies in the range of 0-10 mlU/ml. Even it is usually seen at an approximate value of 0 and 0. With pregnancy, these values increase. That is, we know from the height of this hormone whether pregnancy exists or not.

What Does Low And High Beta HCG Mean?

The height of beta hCG first makes it clear that the person is pregnant. Because pregnancy increases the hormone Beta HCG. This hormone can give false information in some periods. For example, if a person has a different condition, gastritis, some types of pancreatic cancer, some stomach cancers, ovarian cancer, liver tumor, and multiple pregnancy, this hormone can also be elevated in cases such as gastritis. Therefore, it is unlikely that you will understand that you are pregnant only with this test. After that, you must also have different tests. In addition to these, it october possible to say that the nutrients eaten also affect this hormone. Foods high in progesterone, especially dill, avocado, spinach, tomatoes and walnuts, increase the value of Beta HCG.

Beta HCG is normal, that is, it is usually close to 0 and 0 in individuals who are not pregnant. In individuals who are pregnant, a low level of this hormone can be due to many reasons. These are ectopic pregnancy, a deviation in the calculation of the week of pregnancy, sudden miscarriages.

In this article, we have discussed the Beta HCG hormone in detail. We have made explanations for you by including all the questions that are curious. For more information, you can visit our Human IVF page.

HOW TO UNDERSTAND THAT INSEMINATION WAS SUCCESSFUL?

View Details

Insemination treatment is a method of selecting the sperm that is the highest quality of the sperm taken from the expectant father during the ovulation period, that is, during the period when the probability of conception of the expectant mother is the highest, and then putting it into the womb of the expectant mother. A state of fertilization that has been tried many times by natural means, but no successful results have been obtained, thanks to vaccination treatment, sperm and egg dec easily combined and fertilized. So, how will expectant parents understand this situation when Insemination gives a successful result? We will answer this question and give you more detailed information about Insemination treatment. We wish you a pleasant reading in advance.

What is Insemination?

Insemination is a treatment applied by people who want to become parents but have not been able to achieve this condition by natural means. This treatment, which is performed before starting IVF treatment, is aimed at increasing the chances of pregnancy. Insemination takes place exactly as follows;

· Several necessary tests are applied to prospective parents before.

· Male sperm is taken and the best quality sperm is selected by special procedures.

* Spermatozoa are released into the uterus when the woman's eggs are laid. Here this process is known as the vaccination process.

The vaccination method is a method used in cases where the man's sperm count or mobility is low, when there are problems with the excretion of semen during intercourse, when the woman's cervix is narrow. The cause of infertility cannot be explained in any way.

To Whom Is Insemination Therapy Prescribed?

“Who is the Insemination method applied to?"we can explain the question as follows; It is a form of treatment applied to expectant parents who want to have children, but for various reasons some kind of pregnancy condition cannot be created. For the implementation of this treatment, the man or woman must have some problems that he is experiencing. We can list the problems encountered as follows:

· If there is a lack of sperm count and mobility in a man,

· If there is a problem of unexplained infertility (infertility)

· If the woman has ovulation problems and therefore pregnancy could not be done with egg tracking

· It can be applied in couples who want to accelerate the possibility of pregnancy due to social reasons experienced by couples.

What is the Success Rate of Insemination?

With the development of technology in the medical field and the scientific studies conducted, the success rate of Insemination treatment is quite high. And every day these treatments are being enriched with a new way and it is aimed to increase the success rate of Insemination to the highest level.

When Do the Symptoms of Pregnancy Begin With the Success of Insemination?

There is no difference between the occurrence of pregnancy with Insemination and the occurrence of pregnancy by natural means and the appearance of symptoms in terms of the occurrence of pregnancy Dec In other words, expectant mothers are 3rd of pregnancy, as in naturally occurring pregnancies. from the week she begins to experience signs of pregnancy. These symptoms can be considered as complaints such as dizziness, weakness, nausea and vomiting that occur in the morning. Expectant mothers who have these symptoms can find out if they are pregnant by taking a pregnancy test. 12-14 after Insemination to see if pregnancy has occurred. on the day, the Beta HCG hormone is checked in the blood and it is understood whether pregnancy exists or not. If the pregnancy result is positive, you will need to contact your doctor and undergo an examination to keep it under control. After this examination, a clearer result will be obtained by looking at it with ultrasound and it will be determined whether there is a pregnancy or not.

After Insemination, expectant parents should continue their normal lifestyle. They do not need to change anything in their lives with the introduction of Insemination therapy. In this process, they should only take care of regular and balanced nutrition and protect themselves in the best way. We have shared all the details of the vaccination method with you in this article. If you also want to become a parent and are looking for various treatment methods for this, you can check out our page.

WHAT IS COMPREHENSIVE CHROMOSOME SCREENING (NGS)?

View Details

IVF treatments are supported by a wide range of tests and analyzes to get a healthy result. With the help of these tests, problems that may occur before and after pregnancy are also detected and planning is carried out in this direction. NGS, a genetic analysis technology that allows comprehensive chromosome screening to be performed in embryos, is a test that gives extremely effective results as technological developments gain momentum. With NGS, embryos are scanned quickly and effectively, and genetic problems at the chromosome level are detected before pregnancy. The aim of this method is to select a healthy embryo by performing genetic analysis on embryos before the transfer process and to increase the chances of a healthy pregnancy. You can continue reading our article for the details of the NGS test.

What is Comprehensive Chromosome Screening (NGS)?

It is extremely important that the embryos obtained in IVF treatments are successfully transferred to the uterus. But in some cases, pregnancy may not be achieved. One of the most important reasons why a healthy pregnancy cannot be achieved despite embryo transfer in treatment has been identified as chromosome disorders that occur in embryos. In order to achieve a healthy and successful result in IVF treatments, it is necessary to analyze the embryos in detail and detect chromosomal abnormalities. Previously, the multidimensional and complex structure of chromosomes would have made multiple tests necessary. While this situation is quite time consuming and costly, the NGS (Next Generation Sequencing) test appears as a result of the developing technology today. The NGS method is a newly developed genetic analysis technology that allows comprehensive chromosome screening of embryos. The NGS method allows all embryos to be screened within a short period of time. With NGS, which offers a quick and detailed scan, chromosome-related problems are diagnosed before pregnancy. All 24 chromosomes are scanned with the NGS test.

Comprehensive chromosomal screening practices performed by the NGS method play an extremely important role in diagnosing disorders and have an effect on facilitating healthy outcomes in IVF treatments.

What are the Features of the NGS Technique?

Chromosomal abnormalities are determined by screening with the NGS method. Embryos containing more than two or more cell communities with different chromosomal structures are called “mosaic embryos”. Mosaic embryos are detected more easily with the NGS technique. After these chromosomal abnormalities detected by the NGS test are detected accurately and in detail, the process is advanced by including them in the treatment planning. Compared to the different PGD methods used to date and known, the NGS method provides a high-intensity scanning area, allowing you to detect even some genetic disorders, as well as numerical changes occurring in chromosomes.

What Genetic Defects Can Be Detected with NGS-Based PGS?

Embryos obtained in IVF treatment are evaluated according to various criteria in terms of the characteristics they have, and a healthy result is sought by ensuring the transfer of the embryo with the best developmental characteristics to the uterus. Examination of the developmental characteristics of the embryo under a microscope by classical methods does not give a clear information about the chromosomal state of the embryo. This information is only reached by performing a genetic screening with PGS. Even if the embryos have a good quality structure, they can contain various chromosomal problems, and this can also lead to problems such as early miscarriages, some structural disorders in the developing fetus, or the embryo does not hold on to the uterus. The main purpose of using the PGS method, which is an NGS-based method, is to increase the adhesion of the embryo to the uterus, which is found to have a chromosomally normal structure, to reduce the likelihood of miscarriage that may occur later, and as a result, to increase the likelihood of couples having healthy babies. The NGS-based PGS operation is performed by embryologists who have the necessary education and experience in this regard. The process takes a short time and does not cause any harm to the embryo. The PGS process begins by combining the egg taken from the expectant mother and the sperm taken from the expectant father outside the body. 5. Development of embryos from formed embryos. or 6. on the day when the blastocyst is at the stage, several cells are taken by biopsy without damaging the embryo. These received cells are sent to the genetic laboratory for a scan of 24 chromosomes, while the embryos are frozen. At this point, it is extremely important that the procedure is performed by a qualified embryologist so that the embryo does not get damaged. At the end of this examination, the embryo or embryos whose genetic structure has been determined to be healthy are transferred after completion of intrauterine preparation and pregnancy results that reach higher rates are obtained, especially.

To summarize briefly; NGS-based PGS is a genetic screening method and can be used to detect numerical and structural imbalances in chromosomes. However, single gene diseases, especially those with familial transmission, cannot be detected with the PGS method.

Who are the Groups of Patients Who Can Be Administered NGS?

The benefits of the NGS method, which is a new generation genetic analysis technology, also raises the question of which patient groups this technique can be applied to. Before answering this question, we can state that the intended point of the NGS method is to be able to detect numerical and structural changes in chromosomes. Therefore, we can address the question of which people have these changes more often for groups of patients who can be administered NGS. Groups of patients for whom NGS can be applied can be listed as follows;

· In cases of repeated miscarriage,

· in expectant mothers over the age of 38,

· In severe male infertility,

* In cases of infertility, the cause of which is unknown,

· It is applied in cycles of continuous self-recurring treatment failures.

The NGS method, which is a rapidly developing field, is actively used in many countries today due to its possibilities and facilitating and accelerating effects for the process.

What are the Advantages of Preimplantastone Genetic Screening with NGS?

NGS, a new genetic examination method used to screen for 24 chromosomes in embryos, provides the opportunity to examine and sequence the entire human genome both numerically and structurally in a short period of time, such as a single day. It offers us a revolutionary technology in this aspect. The improved NGS method can detect mosaic embryos better than other PGD methods. The main advantages of Preimplantastone Genetic Screening with NGS are that it allows you to quickly scan a large area of genes, both numerically and structurally. In addition to scanning gene fields numerically and structurally, the NGS method also has advantages such as obtaining a more accurate result with a low margin of error, achieving faster results, and having a lower cost. With this method, 24 chromosome screening can also be performed simultaneously with the study of single gene diseases and HLA typing.

Does NGS Damage the Embryo?

IVF treatments are an extremely exciting period for couples. During this period, in order to obtain a healthy result, various tests are applied to the embryos obtained to determine the success rate. In some cases, couples may have a high risk of genetically abnormal embryo development. Advanced maternal age is one of these conditions. Embryos that are not genetically normal are not suitable for transfer. In order to be able to determine the chromosomal status of embryos and to obtain a healthy result, process planning is carried out in the light of the NGS result. Another confusing situation for couples at this point is whether NGS causes any damage to the embryo during the application phase. Doctors who specialize in their field and NGS performed under appropriate conditions do not pose a danger risk to the embryo. At this point, managing and planning the process in accordance with the needs with a reliable specialist and institution will also be an extremely important step.

Does Pregnancy Always Occur With a Smoothly Detected Embryo?

After the tests and examinations, embryos that do not carry any genetic abnormalities are placed in the uterus. The probability of the occurrence of pregnancy after this procedure develops due to various factors. These factors;

· Women's age

· The amount of ovarian reserve of the woman

* Sperm quality

· Embryo quality

· Ensuring a proper intrauterine environment

· The presence of hydrosalpinx

· Conditions encountered during embryo transfer

it can be sorted as follows. All these factors are among the dec that affect the occurrence of pregnancy. From this point of view, it is impossible to say that pregnancy always occurs with an embryo that is detected without problems.

Studies have shown that age-related embryos are less likely to be chromosomally normal. For this reason, pregnancy rates are also decreasing due to the increasing age of women, especially in IVF trials that have not been applied to PGS. In women under the age of forty, NGS-based PGS normal embryos vary between 40 and 60 percent probability with the results of the analysis, the rate falls below twenty percent in people over the age of 40.

In women over the age of forty, a low pregnancy rate is achieved by transferring an embryo that has not been genetically screened with NGS, while this rate is increased by transferring an embryo that has been diagnosed with NGS and is chromosomally normal.

How Many Days Do NGS Results Come Out?

The embryos that have been biopsied are 5 or 6 until they reach the blastocyst stage. by following it up to the day, only embryos that have not been detected as abnormalities are transferred to the expectant mother's uterus (uterus). The NGS process applied to the embryos is completed within the same day. In this way, treatment planning is quickly directed.

What are the NGS Test Prices?

The information obtained from the results of the NGS test gives a comprehensive information for the IVF process. At this point, NGS, a new generation genetic screening test, has entered our lives as a result of high technology. It is a method that also has many advantages, especially if it provides a quick and wide information about the chromosomal state of the embryo. In addition to the advantages it provides, NGS is a method that also has an extremely low cost. This is a situation that also increases the availability of the test. As the Huma IVF family, we continue to be there for our couples during this exciting process. For all your questions about NGS, you can review our site and contact us for detailed information.

In this article, we have included details about the NGS method. It is important to detect embryos that do not have chromosomal abnormalities, as well as to successfully transfer the embryos obtained in IVF treatments to the uterus. Comprehensive chromosomal screening practices performed by the NGS method play an extremely effective role in detecting chromosomal disorders in embryos and increase the risk of a positive outcome of the process.

About Hüma

Private Huma Obstetrics and Gynecology Hospital

Health Tourism Certificate

Hüma was established in March 2004 as the first Women’s Health Center of Kayseri, and expanded its health service to reach more women with the Gynecology and Obstetrics Hospital in 2006 by growing rapidly.

Online Consulting

Contact Us

info@humainternationalhospital.com
+90 552 252 92 90
Tacettin Veli, Mahallesi, Seyyid Burhanettin Blv. No:58, 38150 Melikgazi/Kayseri

The information on our website was created by Hüma Hospital. This information is not intended for therapeutic purposes.

Search

EDUCATION

WORK EXPERIENCE

AREAS OF INTEREST

SCIENTIFIC PUBLICATION BOARD MEMBERSHIPS

SCIENTIFIC PUBLICATIONS

I- Articles

A- Published in Journals Indexed in SSCI, AHCI, or SCI

B- Published in Peer-Reviewed National and International Journals

II- Other Studies (Technical Notes, Comments, Case Reports, Letters to the Editor, etc.)

A- Articles Published in Journals Indexed in SSCI, AHCI, or SCI

B- Articles Published in Peer-Reviewed National and International Journals

C- Articles Published in Non-Peer-Reviewed Journals (Faculty, Institute, Research Center Journals, and Encyclopedic Entries)

I- Review Articles

III- Presented and Published Conference Papers

A- International Conferences

B- National

A- Contribution at the Chapter Level (National)

Contribution as a Special Issue Editor in a Journal (National)

Contribution as a Book Editor (National)

EDUCATION, ADMINISTRATIVE, AND SCIENTIFIC ACTIVITIES

I- Invited Speaker

A- At National Congresses, Conferences, and Symposiums

II- Administrative and Scientific Activities

A- Administrative Experience

B- Scientific and Academic Memberships

C- Editorial Board Membership

D- National and International Research Projects